SyncroDose™ is a novel enabling technology that uses Penwest's unique TIMERx® patented agglomerated hydrophilic matrix system. SyncroDose is the first technology that offers a variety of predetermined lag times, that can control when and where a drug is released, followed by a variety of customized drug-release profiles to include immediate and controlled release.

Some of the disease states that may benefit from chronotherapy are:
Arthritis (Rheumatoid      and Osteo) Asthma Immunologic Disorders       - Allergy       - Inflammation	Cardiovascular Disorders Gastroenterologic       Disorders Neurologic Disorders       - Pain       - Sleep Disorders	Sexual Dysfunction Metabolic Disorders Cancer

It's about when... SyncroDose works with the body's biological clock to customize the delivery of drug, reduce dose and improve efficacy		It's about where... Different SyncroDose formulations provide the ability to deliver the drug to different sites within the gastro-intestinal tract
View Case Study One		View Case Study Two